Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Shares Issued (2023 - 2025)

Mangoceuticals' Shares Issued history spans 3 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $1.3 million; the TTM value through Sep 2025 reached $3.2 million, up 79.29%, while the annual FY2024 figure was $1.3 million, 78.58% down from the prior year.
  • Shares Issued for Q3 2025 was $1.3 million at Mangoceuticals, up from $605785.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.4 million in Q1 2023 and bottomed at $180000.0 in Q1 2024.
  • The 3-year median for Shares Issued is $650000.0 (2023), against an average of $1.1 million.
  • The largest annual shift saw Shares Issued crashed 95.86% in 2024 before it soared 166.67% in 2025.
  • A 3-year view of Shares Issued shows it stood at $1.2 million in 2023, then tumbled by 36.67% to $759998.0 in 2024, then surged by 74.29% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Shares Issued are $1.3 million (Q3 2025), $605785.0 (Q2 2025), and $480000.0 (Q1 2025).